Menu
Back to User profile » Prof. Dr. Heba Ahmed Osman
Papers published by Prof. Dr. Heba Ahmed Osman:
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP
Osman HA, Nafady-Hego H, Nasif KA, Ahmed HA, Mahmoud EAR, Abass NM, Rayan A, Mahmoud MA, Nafady A
International Journal of General Medicine 2023, 16:1047-1058
Published Date: 22 March 2023
Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital’s Patients, Egypt: A Retrospective Study
Ghweil AA, Hassan MH, Khodeary A, Mohamed AO, Mohammed HM, Abdelazez AA, Osman HA, Bazeed SES
Infection and Drug Resistance 2020, 13:2375-2383
Published Date: 17 July 2020
Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer
Ghweil AA, Osman HA, Hassan MH, Sabry AMM, Mahdy RE, Ahmed ARH, Okasha A, Khodeary A, Ameen HH
Cancer Management and Research 2020, 12:117-126
Published Date: 8 January 2020
Management Of Patients With Hepatitis B Virus Reactivation Post–DAA Treatment Of Chronic Hepatitis C Virus Infection In HCV–HBV Coinfected Patients With Pretreatment HBeAg Seroconversion And Early Degree Of Hepatic Fibrosis
Osman HA, Ghweil AA, Sabry AMM, Mahdy RE, Khodeary A
Infection and Drug Resistance 2019, 12:3067-3073
Published Date: 30 September 2019
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]
Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AKA, Ameen HH
Infection and Drug Resistance 2019, 12:1469-1470
Published Date: 29 May 2019
Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, Osman HA, Morsy KH, Hetta HF
Infection and Drug Resistance 2019, 12:273-279
Published Date: 22 January 2019
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AA, Ameen HH
Infection and Drug Resistance 2018, 11:895-901
Published Date: 27 June 2018